Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.2502
0.00 (0.00%)
At close: Oct 21, 2026
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $19.41 million as of October 30, 2026. It is the 37,010th most valuable company in the world and the 5,207th biggest in the United States. Its market cap has increased by 1,483.54% in one year.
Market Cap
19.41M
Enterprise Value
20.24M
Revenue
n/a
Global Rank
Country Rank
#5,207 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2021, Biomind Labs's market cap has increased from 18.69M to 19.41M, an increase of 3.84%. That is a compound annual growth rate of 0.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 35.68M | 303.51% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cell Source | 36.49M |
| ZIVO Bioscience | 35.66M |
| Provectus Biopharmaceuticals | 20.69M |
| Hepion Pharmaceuticals | 20.07M |
| NDT Pharmaceuticals | 16.20M |
| Vicapsys Life Sciences | 14.57M |
| Brainstorm Cell Therapeutics | 13.14M |
| Synlogic | 12.48M |